查看購物車
  • English
  • Japanese
  • Korean
全球免疫診斷市場（2026-2030 年）
市場調查報告書
商品編碼
2125940

全球免疫診斷市場（2026-2030 年）

Global Immunodiagnostics Market 2026-2030
出版日期: | 出版商: TechNavio | 英文 317 Pages | 訂單完成後即時交付

價格
簡介目錄

全球免疫診斷市場預計在 2025 年至 2030 年間成長至 410.86 億美元，預測期內複合年成長率為 14.7%。

本報告對全球免疫診斷市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括：全球慢性病和感染疾病病率的上升、對高通量檢查室自動化系統需求的加速成長以及高靈敏度心臟生物標記在臨床上的廣泛應用。

本報告基於客觀整合的一手和二手訊息，包括來自主要行業相關人員的見解。報告內容涵蓋主要公司分析、全面的市場規模數據、基於細分市場的區域分析數據以及供應商格局。此外，報告還包含歷史數據和預測數據。

市場範圍
基準年 2025
年末 2030
預測期 2026-2030
成長勢頭 加速度
年比比較（2026 年） 13.2%
複合年成長率 14.7%
增量 410.86億美元

本報告指出，未來幾年全球免疫診斷市場成長的關鍵促進因素之一是照護現場（POC​​）分散式免疫檢測平台的普及。此外，人工智慧在免疫檢測結果解讀中的應用以及用於神經退化性疾病早期篩檢的新型生物標記的商業化，預計也將顯著提升市場需求。

目錄

第1章：執行摘要

第2章：Technavio 的分析

  • 分析價格敏感度、生命週期、顧客購買籃子、採用率和購買標準。
  • 輸入的重要性及差異化因素
  • 混淆因素
  • 促進因素和挑戰的影響

第3章 市場狀況

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析

第4章 市場規模評估

  • 市場的定義
  • 市場區隔分析
  • 市場規模（2025 年）
  • 市場展望（2025-2030 年）

第5章：實際市場規模

  • 全球免疫診斷市場（2020-2024）
  • 按產品分類的分析（2020-2024 年）
  • 按應用領域分析（2020-2024 年）
  • 按最終用戶分類的分析（2020-2024 年）
  • 區域分析（2020-2024）
  • 各國分析（2020-2024 年）

第6章 定性分析

  • 人工智慧的影響：全球免疫診斷市場
  • 地緣政治衝突對全球免疫診斷市場的影響。

第7章：五力分析

第8章 市場區隔：依產品

  • 比較：按產品
  • 試劑和耗材
  • 免疫診斷系統
  • 市場機會：依產品分類

第9章 市場區隔：依應用

  • 比較：透過應用
  • 腫瘤和內分泌疾病
  • 肝炎和逆轉錄病毒
  • 感染疾病
  • 胃腸道糞便
  • 其他
  • 市場機會：依應用領域分類

第10章 市場區隔：依最終用戶分類

  • 比較：按最終用戶
  • 診斷檢查室
  • 醫院和診所
  • 學術研究機構
  • 其他
  • 市場機會：依最終用戶分類

第11章 客戶情況

第12章 區域情勢

  • 區域分類
  • 區域比較
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 荷蘭
  • 亞洲
    • 中國
    • 日本
    • 印度
    • 韓國
    • 印尼
    • 泰國
  • 其他地區（ROW）
    • 巴西
    • 沙烏地阿拉伯
    • 土耳其
    • UAE
    • 阿根廷
    • 南非
    • 哥倫比亞
    • 以色列
  • 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場機遇

第14章 競爭格局

  • 概述
  • 競爭格局
  • 混亂局面
  • 產業風險

第15章 競爭分析

  • 公司簡介
  • 公司排名指標
  • 企業市場定位
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • Bio Techne Corp.
  • Danaher Corp.
  • DiaSorin SpA
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd.
  • Merck KGaA
  • QIAGEN NV
  • QuidelOrtho Corp.
  • Revvity Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

第16章附錄

簡介目錄
Product Code: IRTNTR44345

The global immunodiagnostics market is forecasted to grow by USD 41008.6 mn during 2025-2030, accelerating at a CAGR of 14.7% during the forecast period. The report on the global immunodiagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global prevalence of chronic and infectious disease pathology, accelerating demand for high throughput laboratory automation systems, expanding clinical integration of high sensitivity cardiac biomarkers.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year2025
End Year2030
Series Year2026-2030
Growth MomentumAccelerate
YOY 202613.2%
CAGR14.7%
Incremental Value$41008.6 mn

Technavio's global immunodiagnostics market is segmented as below:

By Product

  • Reagents and consumables
  • Immunodiagnostic systems

By Application

  • Oncology and endocrinology
  • Hepatitis and retrovirus
  • Infectious disease
  • GI stool
  • Others

By End-User

  • Diagnostic laboratories
  • Hospitals and clinics
  • Academic and research institutes
  • Others

Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • The Netherlands
  • Asia
  • Rest of World (ROW)
  • Rest of World (ROW)

This study identifies the shift toward point of care decentralized immunoassay testing platforms as one of the prime reasons driving the global immunodiagnostics market growth during the next few years. Also, integration of ai in immunoassay analytical interpretation and commercialization of novel biomarkers for early neurodegenerative screening will lead to sizable demand in the market.

The report on the global immunodiagnostics market covers the following areas:

  • Global immunodiagnostics market sizing
  • Global immunodiagnostics market forecast
  • Global immunodiagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global immunodiagnostics market vendors that include Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., Danaher Corp., DiaSorin SpA, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Grifols SA, Merck KGaA, Promega Corp., QIAGEN N.V., QuidelOrtho Corp., Randox Laboratories Ltd., Revvity Inc., Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc.. Also, the global immunodiagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by Product
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
  • 2.3 Factors of disruption
  • 2.4 Impact of drivers and challenges

3 Market Landscape

  • 3.1 Market ecosystem
  • 3.2 Market characteristics
  • 3.3 Value chain analysis

4 Market Sizing

  • 4.1 Market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2025
  • 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

  • 5.1 Global Immunodiagnostics Market 2020 - 2024
    • Historic Market Size - Data Table on Global Immunodiagnostics Market 2020 - 2024 ($ million)
  • 5.2 Product segment analysis 2020 - 2024
    • Historic Market Size - Product Segment 2020 - 2024 ($ million)
  • 5.3 Application segment analysis 2020 - 2024
    • Historic Market Size - Application Segment 2020 - 2024 ($ million)
  • 5.4 End-user segment analysis 2020 - 2024
    • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
  • 5.5 Geography segment analysis 2020 - 2024
    • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
  • 5.6 Country segment analysis 2020 - 2024
    • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI on global immunodiagnostics market
  • 6.2 Impact of geopolitical conflicts on global immunodiagnostics market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2025 and 2030
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2025 and 2030
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2025 and 2030
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2025 and 2030
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2025 and 2030
  • 7.7 Market condition

8 Market Segmentation by Product

  • 8.1 Market segments
  • 8.2 Comparison by Product
  • 8.3 Reagents and consumables - Market size and forecast 2025-2030
  • 8.4 Immunodiagnostic systems - Market size and forecast 2025-2030
  • 8.5 Market opportunity by Product
    • Market opportunity by Product ($ million)

9 Market Segmentation by Application

  • 9.1 Market segments
  • 9.2 Comparison by Application
  • 9.3 Oncology and endocrinology - Market size and forecast 2025-2030
  • 9.4 Hepatitis and retrovirus - Market size and forecast 2025-2030
  • 9.5 Infectious disease - Market size and forecast 2025-2030
  • 9.6 GI stool - Market size and forecast 2025-2030
  • 9.7 Others - Market size and forecast 2025-2030
  • 9.8 Market opportunity by Application
    • Market opportunity by Application ($ million)

10 Market Segmentation by End-user

  • 10.1 Market segments
  • 10.2 Comparison by End-user
  • 10.3 Diagnostic laboratories - Market size and forecast 2025-2030
  • 10.4 Hospitals and clinics - Market size and forecast 2025-2030
  • 10.5 Academic and research institutes - Market size and forecast 2025-2030
  • 10.6 Others - Market size and forecast 2025-2030
  • 10.7 Market opportunity by End-user
    • Market opportunity by End-user ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
  • 12.2 Geographic comparison
  • 12.3 North America - Market size and forecast 2025-2030
    • 12.3.1 US - Market size and forecast 2025-2030
    • 12.3.2 Canada - Market size and forecast 2025-2030
    • 12.3.3 Mexico - Market size and forecast 2025-2030
  • 12.4 Europe - Market size and forecast 2025-2030
    • 12.4.1 Germany - Market size and forecast 2025-2030
    • 12.4.2 France - Market size and forecast 2025-2030
    • 12.4.3 UK - Market size and forecast 2025-2030
    • 12.4.4 Italy - Market size and forecast 2025-2030
    • 12.4.5 Spain - Market size and forecast 2025-2030
    • 12.4.6 The Netherlands - Market size and forecast 2025-2030
  • 12.5 Asia - Market size and forecast 2025-2030
    • 12.5.1 China - Market size and forecast 2025-2030
    • 12.5.2 Japan - Market size and forecast 2025-2030
    • 12.5.3 India - Market size and forecast 2025-2030
    • 12.5.4 South Korea - Market size and forecast 2025-2030
    • 12.5.5 Indonesia - Market size and forecast 2025-2030
    • 12.5.6 Thailand - Market size and forecast 2025-2030
  • 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
    • 12.6.1 Brazil - Market size and forecast 2025-2030
    • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
    • 12.6.3 Turkey - Market size and forecast 2025-2030
    • 12.6.4 UAE - Market size and forecast 2025-2030
    • 12.6.5 Argentina - Market size and forecast 2025-2030
    • 12.6.6 South Africa - Market size and forecast 2025-2030
    • 12.6.7 Colombia - Market size and forecast 2025-2030
    • 12.6.8 Israel - Market size and forecast 2025-2030
  • 12.7 Market opportunity by geography
    • Market opportunity by geography ($ million)
    • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

  • 13.1 Market drivers
    • Rising global prevalence of chronic and infectious disease pathology
    • Accelerating demand for high throughput laboratory automation systems
    • Expanding clinical integration of high sensitivity cardiac biomarkers
  • 13.2 Market challenges
    • Strict regulatory frameworks and evolving in vitro diagnostic compliance requirements
    • Reimbursement cutbacks and economic pressures on clinical laboratory operations
    • Technical matrix interference and assay standardization deficits across platforms
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2025 and 2030
  • 13.4 Market opportunities
    • Shift toward point of care decentralized immunoassay testing platforms
    • Integration of AI in immunoassay analytical interpretation
    • Commercialization of novel biomarkers for early neurodegenerative screening

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Abbott Laboratories
    • Abbott Laboratories - Overview
    • Abbott Laboratories - Business segments
    • Abbott Laboratories - Key news
    • Abbott Laboratories - Key offerings
    • Abbott Laboratories - Segment focus
    • SWOT
  • 15.5 Agilent Technologies Inc.
    • Agilent Technologies Inc. - Overview
    • Agilent Technologies Inc. - Business segments
    • Agilent Technologies Inc. - Key news
    • Agilent Technologies Inc. - Key offerings
    • Agilent Technologies Inc. - Segment focus
    • SWOT
  • 15.6 Becton Dickinson and Co.
    • Becton Dickinson and Co. - Overview
    • Becton Dickinson and Co. - Business segments
    • Becton Dickinson and Co. - Key news
    • Becton Dickinson and Co. - Key offerings
    • Becton Dickinson and Co. - Segment focus
    • SWOT
  • 15.7 Bio Rad Laboratories Inc.
    • Bio Rad Laboratories Inc. - Overview
    • Bio Rad Laboratories Inc. - Business segments
    • Bio Rad Laboratories Inc. - Key news
    • Bio Rad Laboratories Inc. - Key offerings
    • Bio Rad Laboratories Inc. - Segment focus
    • SWOT
  • 15.8 Bio Techne Corp.
    • Bio Techne Corp. - Overview
    • Bio Techne Corp. - Business segments
    • Bio Techne Corp. - Key news
    • Bio Techne Corp. - Key offerings
    • Bio Techne Corp. - Segment focus
    • SWOT
  • 15.9 Danaher Corp.
    • Danaher Corp. - Overview
    • Danaher Corp. - Business segments
    • Danaher Corp. - Key news
    • Danaher Corp. - Key offerings
    • Danaher Corp. - Segment focus
    • SWOT
  • 15.10 DiaSorin SpA
    • DiaSorin SpA - Overview
    • DiaSorin SpA - Business segments
    • DiaSorin SpA - Key news
    • DiaSorin SpA - Key offerings
    • DiaSorin SpA - Segment focus
    • SWOT
  • 15.11 Eurofins Scientific SE
    • Eurofins Scientific SE - Overview
    • Eurofins Scientific SE - Business segments
    • Eurofins Scientific SE - Key offerings
    • Eurofins Scientific SE - Segment focus
    • SWOT
  • 15.12 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 15.13 Merck KGaA
    • Merck KGaA - Overview
    • Merck KGaA - Business segments
    • Merck KGaA - Key news
    • Merck KGaA - Key offerings
    • Merck KGaA - Segment focus
    • SWOT
  • 15.14 QIAGEN N.V.
    • QIAGEN N.V. - Overview
    • QIAGEN N.V. - Product / Service
    • QIAGEN N.V. - Key offerings
    • SWOT
  • 15.15 QuidelOrtho Corp.
    • QuidelOrtho Corp. - Overview
    • QuidelOrtho Corp. - Business segments
    • QuidelOrtho Corp. - Key offerings
    • QuidelOrtho Corp. - Segment focus
    • SWOT
  • 15.16 Revvity Inc.
    • Revvity Inc. - Overview
    • Revvity Inc. - Business segments
    • Revvity Inc. - Key offerings
    • Revvity Inc. - Segment focus
    • SWOT
  • 15.17 Siemens Healthineers AG
    • Siemens Healthineers AG - Overview
    • Siemens Healthineers AG - Business segments
    • Siemens Healthineers AG - Key offerings
    • Siemens Healthineers AG - Segment focus
    • SWOT
  • 15.18 Thermo Fisher Scientific Inc.
    • Thermo Fisher Scientific Inc. - Overview
    • Thermo Fisher Scientific Inc. - Business segments
    • Thermo Fisher Scientific Inc. - Key news
    • Thermo Fisher Scientific Inc. - Key offerings
    • Thermo Fisher Scientific Inc. - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
    • Market definition
    • Objectives
    • Notes and caveats
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations